ONCBeOne Medicines AG
$354.29+5.9% 1Y
$354.29
$260.2752 weeks$377.47
Is it growing?
Mixed
2 good, 1 to watchNeither accelerating nor breaking down: revenue growing +37% year on year and operating margin widening (+19.2 points), but earnings down −221% year on year.
Revenue trend+37% in a year
Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +47% a year.
Earnings trend−221% in a year
Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.
Margin direction+19.2 points operating
Trailing-twelve-month operating margin, 11.8% now against -7.4% a year earlier.
All from SEC EDGAR, as of Mar 31, 2026.
Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.
Biotechnology
The closest names by size in the same industry